ATE2318T1 - Peptide mit somatostatin-wirkung, sie enthaltende zusammensetzungen und verfahren zur herstellung der peptide. - Google Patents

Peptide mit somatostatin-wirkung, sie enthaltende zusammensetzungen und verfahren zur herstellung der peptide.

Info

Publication number
ATE2318T1
ATE2318T1 AT80101112T AT80101112T ATE2318T1 AT E2318 T1 ATE2318 T1 AT E2318T1 AT 80101112 T AT80101112 T AT 80101112T AT 80101112 T AT80101112 T AT 80101112T AT E2318 T1 ATE2318 T1 AT E2318T1
Authority
AT
Austria
Prior art keywords
peptides
image
tyr
somatostatin
inhibiting
Prior art date
Application number
AT80101112T
Other languages
English (en)
Inventor
Daniel F. Veber
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE2318T1 publication Critical patent/ATE2318T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT80101112T 1979-03-13 1980-03-05 Peptide mit somatostatin-wirkung, sie enthaltende zusammensetzungen und verfahren zur herstellung der peptide. ATE2318T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/020,148 US4190648A (en) 1979-03-13 1979-03-13 Peptides having somatostatin activity
EP80101112A EP0017746B1 (de) 1979-03-13 1980-03-05 Peptide mit Somatostatin-Wirkung, sie enthaltende Zusammensetzungen und Verfahren zur Herstellung der Peptide

Publications (1)

Publication Number Publication Date
ATE2318T1 true ATE2318T1 (de) 1983-02-15

Family

ID=21797013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80101112T ATE2318T1 (de) 1979-03-13 1980-03-05 Peptide mit somatostatin-wirkung, sie enthaltende zusammensetzungen und verfahren zur herstellung der peptide.

Country Status (6)

Country Link
US (1) US4190648A (de)
EP (1) EP0017746B1 (de)
JP (1) JPS55124747A (de)
AT (1) ATE2318T1 (de)
DE (1) DE3061721D1 (de)
DK (1) DK105680A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
EP0029579B1 (de) * 1979-11-27 1983-02-16 Sandoz Ag Polypeptide, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen, die diese Polypeptide enthalten, und ihre Verwendung
EP0031303A3 (de) * 1979-12-21 1981-11-04 Ciba-Geigy Ag Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
DE3379657D1 (en) * 1982-12-06 1989-05-24 Merck & Co Inc Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US4994554A (en) * 1988-05-11 1991-02-19 Immunobiology Research Institute, Inc. Probursin
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
AU8019798A (en) * 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
US7034003B1 (en) 1997-05-13 2006-04-25 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Somatostatin and somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
DK0980253T3 (da) * 1997-05-13 2004-07-05 Sod Conseils Rech Applic Somatostatin og somatostatinagonister til behandling af insulininsensitivitet og syndrom X
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
ES2325880T3 (es) 2001-06-08 2009-09-23 Ipsen Pharma Analogos quimericos de somatostatina-dopamina.
NZ564694A (en) 2003-04-22 2009-11-27 Sod Conseils Rech Applic Peptide vectors
EP3590956A1 (de) 2008-06-12 2020-01-08 Ipsen Bioinnovation Limited Unterdrückung von neuroendokrinen erkrankungen
KR101731655B1 (ko) 2008-06-12 2017-05-11 입센 바이오이노베이션 리미티드 암 억제 방법
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs

Also Published As

Publication number Publication date
US4190648A (en) 1980-02-26
EP0017746A1 (de) 1980-10-29
EP0017746B1 (de) 1983-01-26
DK105680A (da) 1980-09-14
DE3061721D1 (en) 1983-03-03
JPS55124747A (en) 1980-09-26

Similar Documents

Publication Publication Date Title
ATE2318T1 (de) Peptide mit somatostatin-wirkung, sie enthaltende zusammensetzungen und verfahren zur herstellung der peptide.
IE781151L (en) Somatostatin analogs
US4563352A (en) Human pancreatic GRF
ES531585A0 (es) Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina
US4435385A (en) N-Acyl-polypeptides and processes for the production thereof
YU46023B (sh) Postupak za dobijanje novih analoga insulina
DK165749B (da) Grf-analoge peptider og farmaceutisk acceptable salte heraf samt farmaceutisk middel indeholdende disse
JPH0133118B2 (de)
KR900003205A (ko) 제약 화합물
PT77934B (en) Process for the preparation of peptides having influence on the function of the gland pituitary
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
ES8202787A1 (es) Un procedimiento para la preparacion de un hexapeptido ci- clico
HUP0001431A2 (hu) Módosított tandem peptid, ezt tartalmazó immunogén gyógyászati készítmény és vakcina az LHRH hormon termelés ellen, és eljárás a sertéshús minőségének javítására
ATE2622T1 (de) 2-niedrigalkyl-7-substituierte-2 oder 3-cephem-4- carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US4428942A (en) Analogs of somatostatin
AU646451B2 (en) Hybrid calcitonin
KR0163033B1 (ko) Grf 유사체 viia
IE781724L (en) Peptides
EP0107890B1 (de) PGRF von Säugetieren
GB1059854A (en) Improvements in or relating to a cyclic nonapeptide
KR890005149A (ko) 합성 펩타이드 및 이를 포함한 제약학적 조성물
ATE4590T1 (de) Pentapeptide, verfahren zu ihrer herstellung, bei solchen verfahren verwendete zwischenverbindungen, verwendung in pharmazeutischen zusammensetzungen und diese enthaltende zusammensetzungen.
KR920019817A (ko) 초활성 grf 유사체
KR880013970A (ko) 신규한 알킬화 성장 호르몬-방출 펩티드와 그것으로 포유동물을 처리하는 방법
KR920700223A (ko) 비가역적 봄베신 길항제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties